Ameritas Investment Partners, Inc. Karuna Therapeutics, Inc. Transaction History

Ameritas Investment Partners, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$161.33 - $204.36 $30,491 - $38,624	189 Added 7.98%	2,558 $464,000
Q4 2022 Feb 13, 2023	BUY	$191.53 - $236.82 $5,362 - $6,630	28 Added 1.2%	2,369 $465,000
Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $45,678 - $102,367	369 Added 18.71%	2,341 $526,000
Q2 2022 Aug 12, 2022	BUY	$93.97 - $143.33 $21,707 - $33,109	231 Added 13.27%	1,972 $249,000
Q2 2021 Aug 06, 2021	BUY	$107.45 - $135.95 $48,997 - $61,993	456 Added 35.49%	1,741 $198,000
Q1 2021 May 14, 2021	SELL	$95.46 - $133.08 $8,114 - $11,311	-85 Reduced 6.2%	1,285 $154,000
Q2 2020 Aug 05, 2020	BUY	$62.14 - $117.21 $28,584 - $53,916	460 Added 50.55%	1,370 $153,000
Q1 2020 May 13, 2020	BUY	$60.41 - $115.92 $32,017 - $61,437	530 Added 139.47%	910 $66,000
Q3 2019 Nov 14, 2019	BUY	$16.05 - $27.35 $6,099 - $10,393	380 New	380 $6,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.